These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 16194352)

  • 1. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
    Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Lu MQ; Cai CJ; Zhao H; Yang Y; Chen GH
    Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):742-4. PubMed ID: 16836920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
    Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
    J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
    Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention and management of hepatitis B virus reinfection after liver transplantation].
    Ma Y; Tai Q; He XS; Wang GD; Hu AB
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(16):1209-12. PubMed ID: 19781163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation.
    Takaki A; Yagi T; Iwasaki Y; Sadamori H; Matsukawa H; Matsuda H; Shinoura S; Umeda Y; Miyake Y; Terada R; Kobashi H; Sakaguchi K; Tanaka N; Shiratori Y
    Transplantation; 2007 Jan; 83(2):231-3. PubMed ID: 17264822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
    Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
    J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of hepatitis B virus reinfection after orthotopic liver transplantation.
    Wang ZX; Ding GS; Fu H; Zhang JJ; Chen XS; Guo WY; Shi XM; Fu ZR
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):345-8. PubMed ID: 15313666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.
    Yang Y; Zhang Q; Cai CJ; Lu MQ; Li X; Jiang N; Jiang H; Xu C; Li H; Wang GS; Yi SH; Zhang J; Zhang JF; Yi HM; Zhang YC; Chen GH
    Chin Med J (Engl); 2007 Aug; 120(16):1400-3. PubMed ID: 17825167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation.
    Fontana RJ; Hann HW; Wright T; Everson G; Baker A; Schiff ER; Riely C; Anschuetz G; Riker-Hopkins M; Brown N;
    Liver Transpl; 2001 Jun; 7(6):504-10. PubMed ID: 11443577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation].
    Zheng S; Wu J; Wang W; Huang D; Liang T; Lu A
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):445-8. PubMed ID: 12133511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.
    Perrillo RP; Wright T; Rakela J; Levy G; Schiff E; Gish R; Martin P; Dienstag J; Adams P; Dickson R; Anschuetz G; Bell S; Condreay L; Brown N;
    Hepatology; 2001 Feb; 33(2):424-32. PubMed ID: 11172345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and efficacy of "on demand" low-dose immunoprophylaxis in HBV transplanted patients: experience in the Romanian program of liver transplantation.
    Iacob S; Hrehoret D; Matei E; Dorobantu B; Gangone E; Gheorghe L; Popescu I
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):383-8. PubMed ID: 19104697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation.
    Wang ZF; Zhu ZJ; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):509-14. PubMed ID: 16286253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation.
    Ben-Ari Z; Broida E; Kittai Y; Chagnac A; Tur-Kaspa R
    Am J Gastroenterol; 2000 Dec; 95(12):3579-83. PubMed ID: 11151895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center.
    Ikegami T; Soejima Y; Ohta R; Taketomi A; Yoshizumi T; Harada N; Kayashima H; Maehara Y
    Hepatogastroenterology; 2008; 55(85):1445-9. PubMed ID: 18795708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylaxsis against recurrance of hepatitis B virus after liver transplantation].
    Wu JS; Lu SC; Wang ML; Xia RP; Guo QL; Gao DM; Zhang Y; Liu Y; Li N
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):367-9. PubMed ID: 19469177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.